Switch Therapeutics
Revolutionizing RNAi Therapies
Switch Therapeutics was founded in 2020, is headquartered in South San Francisco, United States, lists 11–50 employees, and has $52.0M in recorded funding across 2 rounds.
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- switchthera.com
- Total Funding
- $52.0M
- Last Round
- $52.0M Series AMar 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
Switch Therapeutics is a preclinical-stage biotechnology company founded in 2020 to develop therapeutic applications from RNA interference (RNAi) research pioneered at Caltech, Harvard Medical School, and City of Hope. The company's proprietary CASi (Conditional Activation Switch) platform integrates nucleic acid nanotechnology and RNA biology to create biomarker-gated genetic medicines — therapeutics that activate only in diseased cells expressing specific molecular signals. This programmable, cell-selective approach targets diseases of the central nervous system (CNS) and beyond. Switch raised $52M and moved into its own facility in South San Francisco in early 2022 upon publicly announcing its launch.
Summary
Switch Therapeutics is a Life Sciences company based in South San Francisco, United States, founded in 2020. It lists 11–50 employees. It has raised $52.0M in total across 2 rounds, most recently a $52.0M Series A round in Mar 2023. Investors include Insight Partners, UCB and Eli Lilly.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2023
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/switch-therapeutics"><img src="https://indexed.vc/api/badge/company/switch-therapeutics" alt="Switch Therapeutics on Indexed.vc" width="260" height="76" /></a>